Prognostic factors for regorafenib treatment in patients with refractory metastatic colorectal cancer: A real-life retrospective multi-center study. Biomol Biomed [Internet]. 2023 Nov. 3 [cited 2025 Mar. 10];23(6):1089–1095. Available from: https://www.bjbms.org/ojs/index.php/bjbms/article/view/9253